Table 2 Inhibitory activity of the extracts against two different types of coronaviruses. The results for FCoV inhibition, including EC50 and CC50 values, are shown in Additional file 1: Table S1
From: In vitro efficacy of Artemisia extracts against SARS-CoV-2
Sample | EC50SARS-CoV-2 (mg/mL) | CC50VeroE6 (mg/mL) | Selectivity Index (SARS-CoV-2) |
|---|---|---|---|
A. annua (Chad) | 0.28 ± 0.08 | 1.96 ± 0.82 | 7.00 |
A. annua (Burkina Faso) | 0.12 ± 0.03 | 2.66 ± 1.48 | 22.17 |
A. afra (France) | 0.09 ± 0.03 | 2.36 ± 1.08 | 26.22 |
A. annua var. (Brazil) | 0.13 ± 0.04 | 2.64 ± 1.44 | 20.31 |
A. annua var. CPQBA 1 alcoholic extract | 0.0004 ± 0.0001 | 0.11 ± 0.04 | 275.00 |
Artemisinin | 4.23 ± 1.88 | 18.18 ± 8.6 | 4.30 |
A. annua (USA) | 0.46 ± 0.09 | 1.63 ± 0.63 | 3.54 |